Diagnostic pharmaco-scintigraphy with hepatic intraarterial technetium-99m macroaggregated albumin in the determination of tumour to non-tumour uptake ratio in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Diagnostic pharmaco-scintigraphy with hepatic intraarterial technetium-99m macroaggregated albumin in the determination of tumour to non-tumour uptake ratio in hepatocellular carcinoma

Published:1994-02 Issue:794 Volume:67 Page:136-139
ISSN:0007-1285
Container-title:The British Journal of Radiology
language:en
Short-container-title:BJR

Author:

Lau W Y,Leung T W T,Ho S,Chan M,Leung N W Y,Lin J,Metreweli C,LI A K C

Publisher

British Institute of Radiology

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

http://www.birpublications.org/doi/pdf/10.1259/0007-1285-67-794-136

Reference21 articles.

1. Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump

2. Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion

3. Therapeutic aspects of radio-isotopes in hepatobiliary malignancy

4. Hepatic arterial chemotherapy for primary and metastatic liver cancers

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver Tumor Enhancement at Hybrid Angio-CT and Comparison With Tumor and Hepatic Parenchymal Distribution of Yttrium-90 Microspheres by Positron Emission Tomography;Cureus;2023-12-03

2. Milestones in dosimetry for nuclear medicine therapy;The British Journal of Radiology;2022-07-01

3. Beyond the MAA-Y90 Paradigm: The Evolution of Radioembolization Dosimetry Approaches and Scout Particles;Seminars in Interventional Radiology;2021-11-24

4. Analysis of Hepatocellular Carcinoma Stereotactic Body Radiation Therapy Dose Prescription Method Using Uncomplicated Tumor Control Probability Model;Advances in Radiation Oncology;2021-09

5. Treatment of Primary Liver Tumors and Liver Metastases, Part 1: Nuclear Medicine Techniques;Journal of Nuclear Medicine;2018-08-02